NanoXplore Inc. ("NanoXplore" or the "Company") ( TSX: GRA and OTCQX: NNXPF ), a world-leading graphene company, held its Annual Meeting of Shareholders (the "Meeting") virtually on December 22, 2021. Altogether, 85,364,604 shares (53.99% of outstanding common shares) were accounted for at the Meeting. As part of the formal proceedings, the Company's shareholders elected the Board of Directors and approved the appointment of PricewaterhouseCoopers LLP as independent auditor of the Company. The complete voting results from the Meeting are presented below.

Election of Directors

The Board of Directors fixed at eight the number of directors of the Company to be elected at the Meeting. Each of the eight nominees listed in the Management Information Circular was elected as a director of NanoXplore.   All of the nominee directors were already members of the Board of Directors of the Company.

Nominee Votes For % For Votes Withheld % Withheld
Rob Wildeboer 82,313,650 99.99% 9,200 0.01%
Benoît Gascon 81,089,450 98.50% 1,233,400 1.50%
Soroush Nazarpour 82,318,900 99.99% 3,950 0.01%
Cameron Harris 82,317,650 99.99% 5,200 0.01%
Denis Labrecque 80,999,157 98.39% 1,323,693 1.61%
Arinder S. Mahal 82,188,217 99.84% 134,633 0.16%
Jodie Morgan 82,197,767 99.85% 125,083 0.15%
Nathalie Pilon 82,312,100 99.99% 10,750 0.01%

Appointment of Independent Auditor

PricewaterhouseCoopers LLP, Chartered Professional Accountants, was reappointed as independent auditor of NanoXplore until the close of the next Annual mMeeting of Shareholders, and the directors were authorized to fix the remuneration of the auditor.

Votes For % For Votes Withheld % Withheld
84,344,155 99.98% 18,539 0.02%

About NanoXplore

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities in Canada, the United States and Europe.

For more information, please contact:

Soroush Nazarpour
President & CEO
NanoXplore Inc.
(514) 935-1377

Primary Logo

News Provided by GlobeNewswire via QuoteMedia


NanoXplore Reports Improved Third-Quarter 2022 Financial Results

NanoXplore Inc. ("NanoXplore" or "the Company") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the third quarter ended March 31, 2022.


Keep reading... Show less

NanoXplore and Molding Products Execute Long Term Supply Agreement for GrapheneBlack Enhanced Composite Materials for Transportation Market

NanoXplore Inc. (" NanoXplore " or the " Corporation ") (TSX: GRA and OTCQX: NNXPF) announces that it has entered into a long-term supply agreement with Molding Products LLC to produce and sell graphene-enhanced Sheet Molding Compound ("SMC") called GrapheneBlack™ SMC, used to create high quality, lightweight composite exterior and battery enclosure parts for cars and trucks, such as hoods, bumpers, roofs, and battery packs. GrapheneBlack™ SMC delivers weight reduction of up to 15% vs typical composite parts while also improving surface finish, paintability, and crack resistance. Under the terms of the agreement, both companies can market and sell the new premium grade of SMC under the NanoXplore tradename. Weight reduction is becoming increasingly important for the transportation industry, particularly because electric vehicles are generally heavier than internal combustion engine vehicles and range anxiety could be addressed by reducing the weight of the vehicles. Furthermore, lightweight sheet molding composites are being used increasingly in electric vehicle battery packs that would be complementary to NanoXplore battery related activities.

The agreement with NanoXplore secures a competitive, localized supply of high-quality graphene to produce GrapheneBlack™ SMC as well as R&D support for the development of new graphene-enhanced product grades. NanoXplore is the world's largest manufacturer of sustainable, high-quality, cost-effective graphene with 4,000 metric tons of annual production capacity in Montreal, Canada.

Keep reading... Show less

NanoXplore Inc. to Announce Third Quarter Results Conference Call on Tuesday May 17, 2022, and the Nomination of its Director of Investor Relations

NanoXplore Inc. (TSX: GRA and OTCQX: NNXPF) ("NanoXplore") is pleased to hold a conference call to discuss the results of its third quarter ended March 31, 2022, on Tuesday, May 17, 2022, at 8:30 a.m. Eastern Time. The financial results will be released on Monday, May 16, 2022, after the market close.

Details of the Q3 Conference Call

Keep reading... Show less

Solmax and NanoXplore formalize their relationship after five years of collaboration and innovation through a blanket purchase order

NanoXplore Inc. (" NanoXplore ") (TSX: GRA and OTCQX: NNXPF) and Solmax Group Inc. (" Solmax ") announce that they entered into a blanket purchase order, result of several years of collaborative work.

The five-year collaboration between the two companies has resulted in a product that is the first of its kind in the environmental infrastructure market. "This cooperation underscores our commitment to delivering growth through forward-looking innovation and collaboration," says Solmax CEO, Jean-Louis Vangeluwe. "Our five-year development collaboration with NanoXplore will allow us to launch a next-generation product based on graphene technology that solves some of our customers' sustainability challenges while also boosting performance."

Keep reading... Show less
Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Latest Press Releases

Related News